Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - COMMON STOCK REPURCHASED
Common Stock Repurchased REGN - Regeneron Pharmaceuticals, Inc.
-2.94 B
LAST VALUE
-4.70%
2 YEAR CAGR
-72.61%
5 YEAR CAGR
-31.14%
10 YEAR CAGR